Orotic Aciduria Type 1 Overview

Save information for later
Sign Up

Learn About Orotic Aciduria Type 1

What is the definition of Orotic Aciduria Type 1?
Orotic aciduria type I (OA1), also known as hereditary orotic aciduria, is a condition characterized by elevated levels of orotic acid in the urine. It typically becomes apparent in the first months of life with megaloblastic anemia, as well as delays in physical and intellectual development. OA1 is caused by changes in the UMPS gene and inheritance is autosomal recessive. OA1 differs from other causes of orotic aciduria, which may include mitochondrial disorders, lysinuric protein intolerance, and liver disease.
What are the alternative names for Orotic Aciduria Type 1?
  • Orotic aciduria type 1
  • Hereditary orotic aciduria
  • Hereditary orotic aciduria without megaloblastic anemia
  • Orotate phosphoribosyltransferase and omp decarboxylase deficiency
  • Orotic aciduria II (formerly)
  • Oroticaciduria 1
  • Orotidylic pyrophosphorylase and orotidylic decarboxylase deficiency
  • UMP synthtase deficiency
  • UMPS
  • UMPS deficiency
  • Uridine monophosphate synthase deficiency
  • Uridine monophosphate synthetase deficiency
Who are the top Orotic Aciduria Type 1 Local Doctors?
Elite in Orotic Aciduria Type 1
Arthavan Selvanathan
Elite in Orotic Aciduria Type 1
Arthavan Selvanathan
Westmead, NSW, AU 

Arthavan Selvanathan practices in Westmead, Australia. Selvanathan and is rated as an Elite expert by MediFind in the treatment of Orotic Aciduria Type 1. Their top areas of expertise are Orotic Aciduria Type 1, Ornithine Transcarbamylase Deficiency, N-Acetylglutamate Synthase Deficiency, Urea Cycle Disorders (UCD), and Bone Marrow Transplant.

Experienced in Orotic Aciduria Type 1
Dr. Robert L. Talley
Hematology Oncology | Hematology
Experienced in Orotic Aciduria Type 1
Dr. Robert L. Talley
Hematology Oncology | Hematology

Midwest Oncology Associates LLC

2100 Se Blue Pkwy, Lees Summit Medical Center, 
Lee's Summit, MO 
816-282-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Talley is a Hematologist Oncology specialist and a Hematologist in Lee's Summit, Missouri. Dr. Talley and is rated as an Experienced provider by MediFind in the treatment of Orotic Aciduria Type 1. His top areas of expertise are Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Talley is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Orotic Aciduria Type 1
Dr. Britt H. Bolemon
Hematology Oncology | Hematology | Oncology
Experienced in Orotic Aciduria Type 1
Dr. Britt H. Bolemon
Hematology Oncology | Hematology | Oncology

Prisma Health University Medical Group

890 W Faris Rd, 
Greenville, SC 
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Britt Bolemon is a Hematologist Oncology specialist and a Hematologist in Greenville, South Carolina. Dr. Bolemon and is rated as an Experienced provider by MediFind in the treatment of Orotic Aciduria Type 1. Their top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Lung Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Bolemon is currently accepting new patients.

View All Doctors
What are the latest Orotic Aciduria Type 1 Clinical Trials?
Prospective Study of the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
Prospective Study of the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
Enrollment Status: Recruiting
Publish Date: November 05, 2024

Background: Pyrimidine and purine metabolism disorders (DPPMs) affect how the body metabolizes chemicals called pyrimidines and purines. DPPMs can cause dysfunctions throughout the body, especially in the brain, blood, kidneys, and immune system. People with DPPMs might have no symptoms, mild symptoms, or they may have severe, chronic symptoms, that can be fatal. DPPMs are not well understood, and researchers...

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center